Cetuximab (Erbitux®) is commonly prescribed for two types of cancer: squamous cell carcinoma affecting the head and neck, and advanced cancer of the colon or rectum. It is given via an infusion into a vein once a week until potentially serious side effects occur or until the cancer no longer responds to treatment.
When treating cancer with cetuximab, side effects can be expected; common ones include skin reactions, fatigue, and nausea. Fortunately, if problems occur, they tend to be mild and easily treated. Just to be safe, however, report anything that "just does not seem right" to your healthcare provider.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click